摘要
目的观察孟鲁司特纳治疗小儿轻、中度持续性哮喘的临床效果。方法选取我院收治的74例轻、中度持续性哮喘患儿为研究对象,将其随机分为观察组与对照组,对照组给予布地奈德气雾剂治疗,观察组在对照组基础上加用孟鲁司特纳片治疗,比较两组患儿的临床疗效。结果观察组患儿临床疗效优于对照组(P<0.05),有统计学意义。结论孟鲁司特纳治疗小儿轻、中度持续性哮喘的临床效果显著,值得在临床上推广。
Objective To observe the clinical effect of montelukast sodium in treatment of children with light, moderate persistent asthma. Methods Select 74 cases of light, moderate persistent asthma in children in our hospital as the research object, then they were randomly divided into observation group and control group, the control group was given the treatment of Budesonide aerosol agent, the observation group in the control group based on the use of secretary Meng Lu Turner tablets in the treatment, the clinical efficacy was compared between two groups. Results The observation group with clinical efficacy than the control group （P〈0.05）, there is statistical significance. Conclusion The clinical effect of montelukast sodium in treatment of children with light, moderate persistent asthma significantly, worthy of clinical popularization.
出处
《中国卫生标准管理》
2014年第20期98-100,共3页
China Health Standard Management
关键词
孟鲁司特纳
持续性哮喘
效果观察
Monrus Turner
Persistent asthma
Effect observation
